Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treatment of systolic hypertension and severe asymptomatic aortic regurgitation.

Literature DB >> 19120724

Treatment of systolic hypertension and severe asymptomatic aortic regurgitation.

Joel Handler¹.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2008 PMID： 19120724 PMCID： PMC8673037 DOI： 10.1111/j.1751-7176.2008.00053.x

Source DB: PubMed Journal: J Clin Hypertens (Greenwich) ISSN： 1524-6175 Impact factor: 3.738

× No keyword cloud information.

26 in total

1. Prognostic impact of systolic hypertension on asymptomatic patients with chronic severe aortic regurgitation and initially normal left ventricular performance at rest.

Authors: Phyllis G Supino; Jeffrey S Borer; Edmund M Herrold; Clare A Hochreiter; Jacek Preibisz; Karlheinz Schuleri; Mary J Roman; Paul Kligfield
Journal: Am J Cardiol Date: 2005-10-01 Impact factor: 2.778

2. Long-term vasodilator therapy in patients with severe aortic regurgitation.

Authors: Artur Evangelista; Pilar Tornos; Antonia Sambola; Gaietà Permanyer-Miralda; Jordi Soler-Soler
Journal: N Engl J Med Date: 2005-09-29 Impact factor: 91.245

3. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors: Giuseppe Mancia; Guy De Backer; Anna Dominiczak; Renata Cifkova; Robert Fagard; Giuseppe Germano; Guido Grassi; Anthony M Heagerty; Sverre E Kjeldsen; Stephane Laurent; Krzysztof Narkiewicz; Luis Ruilope; Andrzej Rynkiewicz; Roland E Schmieder; Harry A J Struijker Boudier; Alberto Zanchetti; Alec Vahanian; John Camm; Raffaele De Caterina; Veronica Dean; Kenneth Dickstein; Gerasimos Filippatos; Christian Funck-Brentano; Irene Hellemans; Steen Dalby Kristensen; Keith McGregor; Udo Sechtem; Sigmund Silber; Michal Tendera; Petr Widimsky; José Luis Zamorano; Serap Erdine; Wolfgang Kiowski; Enrico Agabiti-Rosei; Ettore Ambrosioni; Lars H Lindholm; Margus Viigimaa; Stamatis Adamopoulos; Enrico Agabiti-Rosei; Ettore Ambrosioni; Vicente Bertomeu; Denis Clement; Serap Erdine; Csaba Farsang; Dan Gaita; Gregory Lip; Jean-Michel Mallion; Athanasios J Manolis; Peter M Nilsson; Eoin O'Brien; Piotr Ponikowski; Josep Redon; Frank Ruschitzka; Juan Tamargo; Pieter van Zwieten; Bernard Waeber; Bryan Williams
Journal: J Hypertens Date: 2007-06 Impact factor: 4.844

4. Mechanism of increasing systolic coronary flow velocity in patients with aortic regurgitation.

Authors: Teruyoshi Kume; Takahiro Kawamoto; Hiroyuki Okura; Nozomi Watanabe; Eiji Toyota; Yoji Neishi; Renan Sukmawan; Ryotaro Yamada; Takashi Akasaka; Kiyoshi Yoshida
Journal: J Heart Valve Dis Date: 2008-01

Review 5. Valvular heart disease: aortic regurgitation.

Authors: Raffi Bekeredjian; Paul A Grayburn
Journal: Circulation Date: 2005-07-05 Impact factor: 29.690

6. systolic flow augmentation in hearts ejecting into a model of stiff aging vasculature. Influence on myocardial perfusion-demand balance.

Authors: A Saeki; F Recchia; D A Kass
Journal: Circ Res Date: 1995-01 Impact factor: 17.367

Treatment of systolic hypertension and severe asymptomatic aortic regurgitation.

1. Prognostic impact of systolic hypertension on asymptomatic patients with chronic severe aortic regurgitation and initially normal left ventricular performance at rest.

2. Long-term vasodilator therapy in patients with severe aortic regurgitation.

3. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

4. Mechanism of increasing systolic coronary flow velocity in patients with aortic regurgitation.

Review 5. Valvular heart disease: aortic regurgitation.

6. systolic flow augmentation in hearts ejecting into a model of stiff aging vasculature. Influence on myocardial perfusion-demand balance.

7. Usefulness of beta blocker therapy in patients with Takayasu arteritis and moderate or severe aortic regurgitation.

8. The role of diastolic blood pressure when treating isolated systolic hypertension.

9. Nifedipine in asymptomatic patients with severe aortic regurgitation and normal left ventricular function.

10. Six month pilot study of captopril for mildly symptomatic, severe isolated mitral and isolated aortic regurgitation.

1. Elevated blood pressure and risk of aortic valve disease: a cohort analysis of 5.4 million UK adults.